logo
  

Stock Alert: ADMA Biologics Jumps 37%

Shares of ADMA Biologics, Inc. (ADMA) are currently gaining over 37% on Thursday morning despite no stock related news to drive the shares.

U.S. stocks traded sharply lower on Thursday morning, as investors are pessimistic about economic rebound due to spike in COVID-19 cases. Meanwhile, shares of pharma companies are performing better lately driven by the positive reports of COVID-19 vaccine.

ADMA is currently trading at $3.8927, up $1.0527 or 37.07%, on the Nasdaq. The stock has traded between $1.45 and $4.65 in the year-to-date period.

ADMA Biologics will release its second quarter financial results on August 5.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Department store chain Sears is closing down its last store located in its home state of Illinois, CNBC reported. The company, which was founded in Chicago in 1892, plans to shut the shop, located in Simon Property Group's Woodfield Mall, on November 14. Sears' parent company, Transformco, which also manages the real estate, said it plans to maximize the value of the Woodfield Mall property and Amazon said over 1 million people have applied for a job at the tech major as part of its Career Day 2021. Job seekers from more than 170 countries have participated in the virtual event. In addition, more than 2,000 Amazon recruiters offered 30,000 individual career coaching sessions with participants in a single day.
RELATED NEWS
Follow RTT